Full Text (PDF)
Case Report

Parkinson’s Disease and Therapeutic Strategies

Sarat Chandra Yenisetti, Associate Professor, Drosophila Neurobiology Laboratory Department of Zoology, Nagaland University (Central) Lumami, Nagaland 798627, India. , Rajesh Singh Pukhrambam* , Abuno Thepa** , Nukshimenla Jamir** , Limamanen Phom** , Sarat Chandra Yenisetti***

Author Information

Licence:




International Journal of Neurology and Neurosurgery 9(2):p 172-186, Jul-Dec 2017. | DOI: http://dx.doi.org/10.21088/ijnns.0975.0223.9217.16

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Parkinson’s disease is the second most common aged associated neurodegenerative disorder after Alzhiemer affecting approximately 1% of the population above the age 50. James Parkinson for the first time medically described Parkinson disease as a neurological disorder in his famous work “An Essay of the shaking palsy”. The pathological hallmark of PD is selective and progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta of human brain and the accumulation of Lewy bodies in the surviving neurons. Cardinal symptoms of Parkinson’s disease include resting tremor, rigidity, postural instability. Besides motor symptoms, several nonmotor symptoms are manifested many years before the onset of motor symptoms. Parkinson’s disease is classified into sporadic and familial PD. Therapeutic strategies prior to Levodopa and Deep Brain stimulation include bloodletting from the neck, vesicatories, shaking chair, hydrotherapy, spa treatments, light exercise and treating with hyoscyamine, arsenic, morphia, conium, Indian hemp” (cannabis). Though levodopa is the leading treatment for PD, it has many limitations. Stem cell therapy appears to be a promising therapy to replenish degenerated dopaminergic neurons.

Keywords: Parkinson’s Disease; Motor Symptoms; NonMotor Symptoms; Deep Brain Stimulation; Levodopa; Stem Cell Therapy; Biomarkers. 


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijnns.0975.0223.9217.16

Keywords


Article Level Metrics

Last Updated

Tuesday 29 September 2026, 08:41:48 (IST)


2210

Accesses

3
272
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share